4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000621
INTERIM CEO gave up 17,436 shares (to pay taxes)
- INTERIM CEO acquired 38,616 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · INTERIM CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-01 | Exercise or conversion : show line 1 in the form | +9,467 | 1,443,097 | D | ||
| 2025-01-01 | Shares withheld for taxes : show line 2 in the form | −3,904 | $2.48 | $9,682 | 1,439,193 | D |
| 2025-01-02 | Exercise or conversion : show line 3 in the form | +29,149 | 1,468,342 | D | ||
| 2025-01-02 | Shares withheld for taxes : show line 4 in the form | −13,532 | $2.48 | $33,559 | 1,454,810 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-01 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −9,467 | 37,867 | D |
| 2025-01-02 | Grant or award : show line 6 in the form Restricted Stock Units | +88,333 | 88,333 | D |
| 2025-01-02 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −29,149 | 59,184 | D |
Loading xslF345X05/form4-01032025_060101.xml…